| Thomas D Sandager, MD | |
|
12961 27th Ave, Chippewa Falls, WI 54729-5699 | |
| (715) 738-3700 | |
| Not Available |
| Full Name | Thomas D Sandager |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 12961 27th Ave, Chippewa Falls, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306947908 | NPI | - | NPPES |
| 30525300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25697 (Wisconsin) | Primary |
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
In an exchange about racial inequality at December's Democratic presidential primary debate, businessman Andrew Yang highlighted jaw-droppingly different health outcomes between black and white women, and Vermont Sen. Bernie Sanders picked up that thread.
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest University School of Medicine and colleagues.
Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
› Verified 1 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
In an exchange about racial inequality at December's Democratic presidential primary debate, businessman Andrew Yang highlighted jaw-droppingly different health outcomes between black and white women, and Vermont Sen. Bernie Sanders picked up that thread.
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest University School of Medicine and colleagues.
Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
› Verified 1 days ago
| Entity Name | Lakeview Medical Center Inc Of Rice Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
In an exchange about racial inequality at December's Democratic presidential primary debate, businessman Andrew Yang highlighted jaw-droppingly different health outcomes between black and white women, and Vermont Sen. Bernie Sanders picked up that thread.
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest University School of Medicine and colleagues.
Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
› Verified 1 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1952890873 PECOS PAC ID: 5698071173 Enrollment ID: O20180904002962 |
News Archive
In an exchange about racial inequality at December's Democratic presidential primary debate, businessman Andrew Yang highlighted jaw-droppingly different health outcomes between black and white women, and Vermont Sen. Bernie Sanders picked up that thread.
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest University School of Medicine and colleagues.
Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas D Sandager, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 387-5511 | Thomas D Sandager, MD 12961 27th Ave, Chippewa Falls, WI 54729-5699 Ph: (715) 738-3700 |
News Archive
In an exchange about racial inequality at December's Democratic presidential primary debate, businessman Andrew Yang highlighted jaw-droppingly different health outcomes between black and white women, and Vermont Sen. Bernie Sanders picked up that thread.
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest University School of Medicine and colleagues.
Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University of Pennsylvania and the Basser Center for BRCA in Penn's Abramson Cancer Center.
Lexicon Pharmaceuticals, Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions.
› Verified 1 days ago
Matthew A Tomcik, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2509 County Highway I, Chippewa Falls, WI 54729 Phone: 715-723-9138 | |
Kenneth R Mitchell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 1st Ave, Chippewa Falls, WI 54729 Phone: 715-838-5222 | |
Maureen G Vanyo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 1st Ave, Chippewa Falls, WI 54729 Phone: 715-838-5222 | |
Reynaldo C Maniquiz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2655 County Highway I, Chippewa Falls, WI 54729 Phone: 715-726-4200 | |
Mrs. Kristie Lynn Gering, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2829 County Highway I, Suite 2c, Chippewa Falls, WI 54729 Phone: 715-860-2300 Fax: 715-861-2302 | |
Kyle G Van Dyke, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 1st Ave, Chippewa Falls, WI 54729 Phone: 715-720-4400 | |
Dr. Frank Duncan Macdonald Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2655 County Highway I, Chippewa Falls, WI 54729 Phone: 715-726-4200 |